SyntheticGestalt
Latest round
- Series A
Last raised
- Sep 2021
Total raised
- $4M
Investors
- 3
About SyntheticGestalt
SyntheticGestalt focuses on developing AI solutions for molecular design and analysis. The company's headquarters is in London, UK, with operations extending to Japan.SyntheticGestalt specializes in the development of innovative artificial intelligence solutions aimed at the design, discovery, and analysis of small and large molecules. Their core offerings include foundation AI models that utilize advanced Geometric Deep Learning techniques, designed to predict molecular behaviors, particularly in drug discovery and enzyme applications for sustainable manufacturing. These AI models are built on extensive datasets, incorporating 3D and 4D molecular structures to enhance predictive accuracy regarding small molecule-protein interactions. The company addresses critical challenges in drug discovery, aiming to reduce the average development timeline and costs associated with new drug creation., Ltd.SyntheticGestalt generates revenue through collaborative partnerships and research agreements with pharmaceutical companies and academic institutions. The company engages in joint development projects, wherein clients leverage SyntheticGestalt's AI-powered platforms for drug discovery and enzyme identification. Revenue may be structured around project-based payments, grants, or milestone achievements in the research process. Clients benefit from specialized AI solutions tailored to their proprietary datasets, enhancing their R&D capabilities while SyntheticGestalt earns revenue through successful outcomes in discovery initiatives. The company plans to expand its operations into new markets in Asia and Europe by 2023.
Who invested in SyntheticGestalt
3 investors across 1 round
See all investors in SyntheticGestalt
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Sep 21, 2021
Amount
$4M
Investors
Questions about SyntheticGestalt
Who invested in SyntheticGestalt?
SyntheticGestalt has 3 investors on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has SyntheticGestalt raised?
SyntheticGestalt has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did SyntheticGestalt last raise money?
SyntheticGestalt's most recent round on record is a Series A, in Sep 2021.
What does SyntheticGestalt do?
SyntheticGestalt focuses on developing AI solutions for molecular design and analysis.
Where is SyntheticGestalt headquartered?
SyntheticGestalt is headquartered in London, UK.
Which VCs invest in companies like SyntheticGestalt?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Highland Europe back pharmaceuticals companies at SyntheticGestalt's stage. Their profiles are linked below.
VCs backing pharmaceuticals startups at Series A
Raising like SyntheticGestalt? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.